Effect of aprotinin on blood loss and myocardial damage in patients undergoing aortocoronary bypass surgery

Abstract

High dose aprotinin therapy showed certain benefits in protecting against perioperative myocardial ischemic injury during aortic cross clamping time in patients undergoing cardiopulmonary bypass surgery. Compared with the control group significantly lower levels of the highly specific marker of cardiac injury, troponin T, could be detected.